The usefulness of L-FABP(liver-type fatty acid binding protein) as a biomarker of renal ischemic injury during pediatric living donor renal transplantation, single center experience.

The usefulness of L-FABP(liver-type fatty acid binding protein) as a biomarker of renal ischemic injury during pediatric living donor renal transplantation, single center experience. - L-FABP(liver-type fatty acid binding protein) as a biomarker of renal ischemic injury during pediatric renal transplantation.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014281

Enrollment

Registered

2014-06-16

Start date

2010-03-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric living donor renal transplantation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with written informed consent(or by next of kin).

Exclusion criteria

Exclusion criteria: Patients without written informed consent(or by next of kin).

Design outcomes

Primary

Measure	Time frame
The concentrations of urinary liver-type fatty acid binding protein during pediatric renal transplantation.	—

Countries

Japan

Contacts

Public ContactRikizo Kogawa

Toho University School of Medicine Department of Anesthesiology

rikizo.kogawa@med.toho-u.ac.jp03-3762-4151

Outcome results